35 min listen
Managing Adverse Events of Novel Antibody-Drug Conjugates in Breast Cancer
FromKeeping Current
ratings:
Length:
19 minutes
Released:
Jun 28, 2023
Format:
Podcast episode
Description
Do you know the best practice strategies for preventing and managing adverse events with antibody-drug conjugates (ADCs) in breast cancer? Credit available for this activity expires: 6/27/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/993692?ecd=bdc_podcast_libsyn_mscpedu
Released:
Jun 28, 2023
Format:
Podcast episode
Titles in the series (99)
Clinical Trials in Focus: Durability of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies: Do you know how study designs influence the data with anti-vascular endothelial growth factor (anti-VEGF) therapies? Find out more. Earn Credit / Learning Objectives & Disclosures: by Keeping Current